Stock Code: 002622 Stock Abbreviation: Haochen Medical Announcement No.: 2026-018
Haochen Medical Technology Co., Ltd. Announcement on the Progress of Litigation Involving the Company
The Company and the entire Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Haochen Medical Technology Co., Ltd. (hereinafter referred to as the "Company") recently received the "Execution Notice" and "Report of Property Order" (2026) Hu 74 Execution Re-execution No. 43 issued by the Shanghai Financial Court. The relevant situation is hereby announced as follows:
I. Basic Situation of the Litigation Case
On July 29, 2020, Jin Huitang Asset Management Co., Ltd. filed a lawsuit with the Shanghai Financial Court due to a contract dispute with Zuo Jiahua, the Company, and Yin Hongwei. After trial, the Shanghai Financial Court issued the "Civil Judgment" (2020) Hu 74 Civil First Instance No. 1514, ruling that the defendant Zuo Jiahua shall pay Jin Huitang Asset Management Co., Ltd. the repurchase amount of RMB 362,298,413.97 and the repurchase amount calculated from June 16, 2020, to the date of actual payment (based on RMB 294,173,029.62, calculated at an annual interest rate of 9%); the defendant Yin Hongwei shall bear joint and several liability for the payment of the first item of obligation by the defendant Zuo Jiahua. After bearing the guarantee liability, the defendant Yin Hongwei has the right to seek recourse from the defendant Zuo Jiahua; the Company shall bear half of the compensation liability for the portion that the defendant Zuo Jiahua fails to pay for the first item of obligation.
On September 9, 2022, the Company received the "Civil Judgment" (2021) Hu Min Final No. 649 served by the Shanghai High People's Court, which dismissed the Company's appeal and upheld the original judgment. Dissatisfied with the civil judgment (2021) Hu Min Final No. 649 of the Shanghai High People's Court, the Company applied for retrial to the Supreme People's Court. The Supreme People's Court transferred the case to the Shanghai High People's Court for review. On June 19, 2023, the Shanghai High People's Court issued the "Civil Ruling" (2023) Hu Min Shen No. 1431, ruling to dismiss the Company's retrial application.